A detailed history of Capital Investment Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 4,225 shares of NVS stock, worth $440,583. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,225
Previous 4,638 8.9%
Holding current value
$440,583
Previous $493,000 1.62%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$106.13 - $120.89 $43,831 - $49,927
-413 Reduced 8.9%
4,225 $485,000
Q2 2024

Jul 12, 2024

BUY
$92.57 - $107.37 $11,293 - $13,099
122 Added 2.7%
4,638 $493,000
Q1 2024

Apr 15, 2024

BUY
$95.27 - $108.47 $2,667 - $3,037
28 Added 0.62%
4,516 $436,000
Q4 2023

Jan 05, 2024

BUY
$92.27 - $101.54 $32,663 - $35,945
354 Added 8.56%
4,488 $453,000
Q3 2023

Oct 16, 2023

SELL
$94.73 - $105.13 $6,252 - $6,938
-66 Reduced 1.57%
4,134 $421,000
Q2 2023

Jul 11, 2023

SELL
$92.52 - $104.91 $7,864 - $8,917
-85 Reduced 1.98%
4,200 $423,000
Q1 2023

Apr 10, 2023

SELL
$80.03 - $92.81 $102,118 - $118,425
-1,276 Reduced 22.95%
4,285 $394,000
Q4 2022

Jan 05, 2023

SELL
$75.55 - $92.52 $4,381 - $5,366
-58 Reduced 1.03%
5,561 $504,000
Q3 2022

Oct 05, 2022

SELL
$74.61 - $87.26 $33,052 - $38,656
-443 Reduced 7.31%
5,619 $427,000
Q2 2022

Jul 06, 2022

BUY
$80.52 - $93.75 $22,062 - $25,687
274 Added 4.73%
6,062 $512,000
Q1 2022

Apr 13, 2022

BUY
$80.11 - $90.62 $1,361 - $1,540
17 Added 0.29%
5,788 $508,000
Q4 2021

Jan 10, 2022

SELL
$79.7 - $88.13 $25,902 - $28,642
-325 Reduced 5.33%
5,771 $505,000
Q3 2021

Oct 13, 2021

SELL
$81.78 - $95.14 $14,393 - $16,744
-176 Reduced 2.81%
6,096 $499,000
Q2 2021

Jul 14, 2021

BUY
$85.24 - $94.15 $8,609 - $9,509
101 Added 1.64%
6,272 $572,000
Q1 2021

Apr 27, 2021

SELL
$83.5 - $98.47 $19,873 - $23,435
-238 Reduced 3.71%
6,171 $527,000
Q4 2020

Jan 21, 2021

BUY
$78.07 - $94.43 $1,014 - $1,227
13 Added 0.2%
6,409 $605,000
Q2 2020

Jul 20, 2020

BUY
$80.93 - $91.1 $971 - $1,093
12 Added 0.19%
6,396 $559,000
Q1 2020

Apr 13, 2020

SELL
$70.67 - $99.01 $16,536 - $23,168
-234 Reduced 3.54%
6,384 $526,000
Q4 2019

Jan 21, 2020

SELL
$84.35 - $95.37 $15,604 - $17,643
-185 Reduced 2.72%
6,618 $627,000
Q3 2019

Oct 24, 2019

BUY
$85.54 - $94.26 $427 - $471
5 Added 0.07%
6,803 $591,000
Q2 2019

Jul 17, 2019

BUY
$75.4 - $92.8 $5,278 - $6,496
70 Added 1.04%
6,798 $621,000
Q1 2019

Apr 11, 2019

SELL
$75.32 - $86.15 $1,129 - $1,292
-15 Reduced 0.22%
6,728 $647,000
Q4 2018

Jan 17, 2019

BUY
$73.66 - $82.02 $63,568 - $70,783
863 Added 14.68%
6,743 $579,000
Q3 2018

Oct 15, 2018

BUY
$66.94 - $77.43 $2,677 - $3,097
40 Added 0.68%
5,880 $507,000
Q2 2018

Jul 10, 2018

BUY
$64.91 - $73.36 $62,378 - $70,498
961 Added 19.7%
5,840 $441,000
Q1 2018

Apr 16, 2018

BUY
$70.39 - $84.15 $68,700 - $82,130
976 Added 25.01%
4,879 $394,000
Q4 2017

Jan 17, 2018

BUY
$72.33 - $77.64 $1,157 - $1,242
16 Added 0.41%
3,903 $328,000
Q3 2017

Oct 17, 2017

BUY
$74.14 - $77.27 $288,182 - $300,348
3,887
3,887 $334,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Capital Investment Advisors, LLC Portfolio

Follow Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.